SLXN Corporate Update: EGM Postponed, KRAS Therapy Gains Momentum, & Key Shareholder Proposals
Explore Silexion Therapeutics’ latest updates: postponed EGM, share‑capital plans, promising KRAS‑pancreatic therapy data, and key market insights.
- SILEXION THERAPEUTICS CORP
- Israel
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read